In this article , the data and p value of the Western Blot histogram were found. Due to the software operation error, a calculation error occurred. After repeated quantitative review several times in the proofing review stage, we reconfirmed the gray value of the Western Blot band, so modified. The Western Blot histogram in the picture and the p value marked in the legend part of the Figure legends, the corrected Figs. 2, 3, 4, 5 and 6 and its legends are given in this correction.
Jin X, Qiu X, Huang Y, Zhang H, Chen K. miR-223–3p carried by cancer-associated fibroblast microvesicles targets SORBS1 to modulate the progression of gastric cancer. Cancer Cell Int. 2022;22:96. https://doi.org/10.1186/s12935-022-02513-1.
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
Jin, X., Qiu, X., Huang, Y. et al. Correction to: miR-223-3p carried by cancer-associated fibroblast microvesicles targets SORBS1 to modulate the progression of gastric cancer.
Cancer Cell Int22, 159 (2022). https://doi.org/10.1186/s12935-022-02571-5